215 related articles for article (PubMed ID: 10704615)
1. Hyperlipemic-very low density lipoprotein, intermediate density lipoprotein and low density lipoprotein act synergistically with serotonin on vascular smooth muscle cell proliferation.
Koba S; Pakala R; Katagiri T; Benedict CR
Atherosclerosis; 2000 Mar; 149(1):61-7. PubMed ID: 10704615
[TBL] [Abstract][Full Text] [Related]
2. Vascular smooth muscle proliferation: synergistic interaction between serotonin and low density lipoproteins.
Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
J Am Coll Cardiol; 1999 Nov; 34(5):1644-51. PubMed ID: 10551718
[TBL] [Abstract][Full Text] [Related]
3. Synergistic interaction between thromboxane A2 and mildly oxidized low density lipoproteins on vascular smooth muscle cell proliferation.
Koba S; Pakala R; Watanabe T; Katagiri T; Benedict CR
Prostaglandins Leukot Essent Fatty Acids; 2000 Dec; 63(6):329-35. PubMed ID: 11133169
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylcholine and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Koba S; Katagiri T; Benedict CR
Circulation; 2001 Mar; 103(10):1440-5. PubMed ID: 11245650
[TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoproteins potentiate the mitogenic effect of 5-hydroxytryptamine on vascular smooth muscle cells.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Jpn Heart J; 2002 Jan; 43(1):35-42. PubMed ID: 12041887
[TBL] [Abstract][Full Text] [Related]
6. Human urotensin-II potentiates the mitogenic effect of mildly oxidized low-density lipoprotein on vascular smooth muscle cells: comparison with other vasoactive agents and hydrogen peroxide.
Watanabe T; Takahashi K; Kanome T; Hongo S; Miyazaki A; Koba S; Katagiri T; Pakara R; Benedict CR
Hypertens Res; 2006 Oct; 29(10):821-31. PubMed ID: 17283870
[TBL] [Abstract][Full Text] [Related]
7. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
[TBL] [Abstract][Full Text] [Related]
8. The very low- and intermediate-density lipoprotein fraction isolated from apolipoprotein E-knockout mice transforms macrophages to foam cells through an apolipoprotein E-independent pathway.
Hakamata H; Sakaguchi H; Zhang C; Sakashita N; Suzuki H; Miyazaki A; Takeya M; Takahashi K; Kitamura N; Horiuchi S
Biochemistry; 1998 Sep; 37(39):13720-7. PubMed ID: 9753460
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Cardiovasc Pharmacol; 2002 Mar; 39(3):449-59. PubMed ID: 11862125
[TBL] [Abstract][Full Text] [Related]
10. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits.
Kita T; Brown MS; Bilheimer DW; Goldstein JL
Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5693-7. PubMed ID: 6957885
[TBL] [Abstract][Full Text] [Related]
11. Effect of lipoproteins on mesangial cell proliferation.
Nishida Y; Oda H; Yorioka N
Kidney Int Suppl; 1999 Jul; 71():S51-3. PubMed ID: 10412737
[TBL] [Abstract][Full Text] [Related]
12. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant N-acetylcysteine inhibits vasoactive agents-potentiated mitogenic effect of mildly oxidized LDL on vascular smooth muscle cells.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Hypertens Res; 2002 Mar; 25(2):311-5. PubMed ID: 12047048
[TBL] [Abstract][Full Text] [Related]
14. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants.
Nordestgaard BG; Tybjaerg-Hansen A; Lewis B
Arterioscler Thromb; 1992 Jan; 12(1):6-18. PubMed ID: 1731859
[TBL] [Abstract][Full Text] [Related]
15. IDL, VLDL, chylomicrons and atherosclerosis.
Nordestgaard BG; Tybjaerg-Hansen A
Eur J Epidemiol; 1992 May; 8 Suppl 1():92-8. PubMed ID: 1505659
[TBL] [Abstract][Full Text] [Related]
16. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism.
Cuthbert JA; Lipsky PE
J Clin Invest; 1984 Apr; 73(4):992-1003. PubMed ID: 6323541
[TBL] [Abstract][Full Text] [Related]
17. Intermediate density lipoprotein levels are strong predictors of the extent of aortic atherosclerosis in the St. Thomas's Hospital rabbit strain.
Nordestgaard BG; Lewis B
Atherosclerosis; 1991 Mar; 87(1):39-46. PubMed ID: 1872923
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein secretion in lean and obese Zucker female rats in vivo and in a single-pass-perfused liver preparation.
Petit D; Wang SR; Renaud G; Infante R
Arch Int Physiol Biochim; 1988 Mar; 96(1):51-62. PubMed ID: 2460049
[TBL] [Abstract][Full Text] [Related]
19. Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Hypertens; 2001 Jun; 19(6):1065-73. PubMed ID: 11403355
[TBL] [Abstract][Full Text] [Related]
20. Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension.
Ryomoto KI; Suzuki M; Kanazawa A; Hasegawa M; Kimura Y; Yamamura T; Harano Y
Am J Hypertens; 2000 Jun; 13(6 Pt 1):617-24. PubMed ID: 10912744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
